CA-XPRIZE
22.12.2020 22:02:12 CET | Business Wire | Press release
XPRIZE , a nonprofit organization that uses global competitions to crowdsource solutions to some of the world’s biggest challenges, is pleased to announce that, following last week’s pitch slam, Luminosity Lab from the United States has been named the grand prize winner of the organization’s Next-Gen Mask Challenge . Selected by the competition’s panel of judges, which included a diverse set of industry professionals and executives, Luminosity Lab was chosen from the other finalists for their mask’s design, x-factor of style, early assessments of accessibility and functionality. The winning team is student-led and developed the FloeMask, which uses a bifurcated filtration chamber to achieve filtration and breathability for use everyday and during exercise, diverting heat from the wearer’s face.
Luminosity Lab is from Arizona State University in Tempe, Arizona and includes Nikhil Dave (age 20), Tarun Suresh (age 22), Katie Sue Pascavis (age 19), John Patterson (age 22) and Jerina Winter Gabriel (age 20). The team of five felt compelled to spring into action after witnessing the devastating impact the COVID-19 pandemic had on their Arizona community. Within the first few months of the crisis, the students behind Luminosity Lab helped develop the PPE Response Network , which was responsible for crowdsourcing 3D printers across Arizona to create and distribute over 15,000 units of PPE to clinics facing shortages, and designed two patent-pending technologies capable of sterilizing disposable N95 masks for reuse. Their participation in the XPRIZE Next-Gen Mask Challenge was driven by their desire to design a better way to protect those that choose to wear a mask and help communities around the world. The winning team will receive a total prize purse of $500,000, exiting the competition with the network and knowledge needed to further refine their prototype, and ensure it meets filtration requirements, should they decide to bring their design to market in the future.
In addition, two teams, Polair from John Hopkins University in Maryland and Naija Force from Abuja, Nigeria, have been named runners up in the competition and will split $500,000 as the two category winners. Team Polair, composed of 25 engineering undergraduates, was chosen as the Future Forward Award winner and won $250,000 for their prototype’s modular design which allows users to swap out mask bodies and choose a filter based on their environment. Naija Force won $250,000 as the winner of the ‘Mass’k Appeal Award for the transparent face mask they designed, which features straps that can be worn over the ear or on-head. These teams will now begin the process of refining their mask to ensure they meet key filtration metrics.
Launched this July amid the COVID-19 pandemic, the XPRIZE Next-Gen Mask Challenge, sponsored by Salesforce CEO Marc Benioff and CNBC host Jim Cramer, asked young inventors between the ages of 15-24 to develop the next generation of protective face masks. Throughout the competition, teams had the opportunity to interact with the challenge’s seven industry partners, who lent their expertise to contestants, including: 3M , Autodesk Inc. , Bryan Cave Leighton Paisner LLP, Honeywell , Lydall, National Association of Manufacturers (NAM) and Under Armour . The competition, which received record entries with 992 teams from 76 countries expressing interest within two months, encouraged teams to design a face mask that overcame at least five of the top ten barriers to mask-wearing, as defined by an XPRIZE-conducted survey. Those common barriers to use included: fogging of glasses, getting too hot, being uncomfortable, causing breathing difficulties, making conversations challenging, prohibiting exercise while wearing, causing pain or not fitting properly, blocking facial expressions, preventing eating or drinking, not being eco-friendly, looking ugly or boring, and difficulty acquiring.
Winning teams were chosen, and final judging was conducted by a panel of experts that included:
- Ashish Diwanji, president of Lydall Performance Materials
- Brian Hovey, vice president, marketing and commercial excellence at Honeywell
- Denise Rutherford, senior vice president - corporate affairs at 3M
- Dr. Erik Viirre, professor at University of California San Diego’s Department of Neurosciences and director at the Arthur C. Clarke Center for Human Imagination
- Garret Gerson, CEO of Calamigos Ranch
- Heather Hughes, group vice president/general merchandise manager seasonal, general merchandise and photo at Walgreens
- June Ambrose, award-winning creative director, author, costume designer and celebrity stylist
- Dr. Kimberly Prather, professor and distinguished chair in atmospheric chemistry at University of California San Diego
- Summer Chamblin, Gen-Z entrepreneur, content creator and daughter of June Ambrose
- Suzanne DiBianca, chief impact officer at Salesforce
Additionally, XPRIZE is pleased to share that team Novus has won the $10,000 People’s Vote Bonus Award which was open to all Next-Gen Mask Challenge top twenty-five teams. The social media-based competition asked teams to defend their design and share their best elevator pitch with their friends, families and followers on social media. Team Novus, based in India, received the most engagement across their social media channels with over 3,000 reactions and interactions on the posts that featured their elevator pitch explaining their design.
"We are absolutely thrilled to be the winners of the Next-Gen Mask Challenge, and are extremely grateful to XPRIZE and all of the incredible sponsors and partners of this event,” said Nikhil Dave of Luminosity Lab. “Since COVID-19 first hit our community in March, we have sought out every way in which we can help - whether it be through crowdsourcing 3D-printed PPE, developing sterilization systems for N95 masks, or even designing our own next-generation mask. We can’t wait to continue pushing to support our global community in every way possible and are absolutely thrilled to have the opportunity to continue this work with the support and encouragement of XPRIZE.”
“We congratulate the winners of the competition,” said Jim Cramer, the host of Mad Money on CNBC. “When we started this journey, we wanted to create awareness among young people for the need to wear masks. We are gratified to have so many entries from around the world. Now the hard work begins as our young champions set out to develop these masks into ones that will be demonstrated to be effective and can be worn around the globe to try to stop the spread of COVID-19.”
“Wearing a mask is one of the most important steps we can take in defeating this pandemic,” said Marc Benioff. “The XPRIZE Next-Gen Mask Challenge has unleashed the talent of some of the most incredible young innovators who are eager to help create a healthier future for us all.”
Teams will receive their winnings within sixty days and will work independently as they choose to finalize their prototypes utilizing the insight provided throughout the competition and final feedback from the judges. Those interested in following along can do so at xprize.org/mask , theluminositylab.com , teampolair.com and teamnaijaforce.com.ng . For additional information on XPRIZE, please visit www.xprize.org .
ABOUT XPRIZE
XPRIZE, a 501(c)(3) nonprofit, is the global leader in designing and implementing innovative competition models to solve the world’s grandest challenges. Active competitions include the $20 Million NRG COSIA Carbon XPRIZE, the $10 Million Rainforest XPRIZE, the $10 Million ANA Avatar XPRIZE, the $5 Million IBM Watson AI XPRIZE and the $5 Million XPRIZE Rapid Reskilling. For more information, visit xprize.org .
View source version on businesswire.com: https://www.businesswire.com/news/home/20201222005657/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
